LSNE Successfully Completes MHRA Inspection

August 7, 2013

Lyophilization Services of New England (LSNE) received a Certificate of GMP Compliance for its New Hampshire facility.

The CMO Lyophilization Services of New England (LSNE) reports that its manufacturing facility in Bedford, New Hampshire has received a Certificate of GMP Compliance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture aseptic lyophilized drug products for use in the European Union. LSNE underwent an initial inspection in May 2013 and was found to be compliant with EU GMP with no critical or major findings. After completion of an audit and registration, LSNE was issued a Certificate of GMP Compliance of a Pharmaceutical Manufacturer from the MHRA. The Bedford facility is now certified for the manufacture of sterile lyophilized drug products to be marketed in the EU.

Source: LSNE